James Metz, MD
OncoLink Associate Editor
Ultima Vez Modificado: 20 de mayo del 2000
Presenter: T.J. Stinson
Affiliation: Northwestern University
It has long been assumed by health insurance companies that clinical trial costs are much larger than those incurred in standard practice. For this reason, both medicare and private insurers have not reimbursed charges for patients in clinical trials. Only 3-8% of adult cancer participants are on clinical trials. This trial was performed to compare the costs of enrolling patients on Phase II clinical trials to the costs of standard medical care.
Materials and Methods:
This pilot study provides evidence to counter the assumption that clinical trials are much more expensive than standard medical treatments. Larger studies are needed to confirm the results presented at this meeting
Feb 1, 2010 - Treatment with a prostate-specific antigen-targeted poxviral vaccine substantially improves overall survival among metastatic prostate cancer patients, according to the results of a phase II study published online Jan. 25 in the Journal of Clinical Oncology.
Feb 1, 2010
Nov 2, 2010
Jul 26, 2014
Apr 16, 2010
Jan 20, 2012
May 25, 2012